Hi Slider,
I agree with you on the lack of reporting and transparency from Kazia, and sadly that seemingly has gotten worse recently. I think John needs to settle in, step up, be visible and provide regular investor updates. I hope to see him improve things soon.
However, I also think we need to acknowledge some of the pros and cons of the strategy of having 3rd party lead trials. Kazia has saved significant capital in having a large number of these trials run by world renowned researchers and medical institutions. The obvious problem is that Kazia loses control of the trials and the reporting to a large extent. This is on top of trying to manage the inherent issues with forecasting and the timely gathering, processing and reporting of trial data. Notwithstanding, I think Kazia could be significantly more transparent and timely with providing relevant updates and details to the market.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia announces change to Board of Directors
Ann: Kazia announces change to Board of Directors, page-13
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
LU7
Discover the strong preliminary feasibility of the Bécancour Lithium Refinery, showcasing resilience in a low pricing environment and a strategic plan to capitalize on future price recoveries
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost